Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$173.1B | 5.5 | 7.4% | 18.6% | 5.3% | (10.1%) | (39.4%) | 173.6% | 4.0% | 41.2% | |
$743.9B | 7.9 | 15.1% | 32.0% | 31.8% | 6.2% | 106.1% | 94.5% | (31.9%) | N/A | |
$398.7B | 3.2 | 1.6% | 4.3% | 1.4% | (0.6%) | (52.0%) | 81.3% | (1.9%) | (1.0%) | |
$375.8B | 4.9 | 11.1% | 3.7% | 5.6% | (14.6%) | (11.7%) | 407.8% | 6.9% | (19.2%) | |
$346.3B | 8.2 | 18.9% | 25.0% | 23.5% | 6.7% | (17.3%) | 22.6% | 14.5% | 0.0% | |
$240.8B | 8.8 | 6.5% | 6.7% | 1.6% | 11.9% | 4,393.3% | 33.1% | 12.7% | 97.9% | |
$232.5B | 8.7 | 17.3% | 18.0% | 6.0% | 34.5% | 18.5% | (0.8%) | 70.2% | 10.8% | |
$223.3B | 5.8 | 1.0% | 0.1% | 2.3% | 3.0% | (17.7%) | 39.5% | 4.0% | 19.8% | |
$148.1B | 5.9 | 4.2% | 8.8% | (1.1%) | (13.5%) | 272.8% | 108.5% | (0.3%) | 105.2% | |
$146.8B | 4.9 | 3.3% | (22.5%) | 11.6% | 20.9% | 3.0% | (4.9%) | N/A | N/A | |
$143.2B | 6.0 | 5.1% | 6.0% | (0.3%) | (38.3%) | (91.6%) | 1,993.4% | 4.7% | 40.8% |
The Amgen Inc. (AMGN) revenue growth is 18.6%, which is lower than the industry median of 6.0% and the 5-year historical average of 6.2%.
The Amgen Inc. (AMGN) operating income growth is (19.9%), compared to the industry median of 22.1% and the 5-year historical average of (5.9%).
The Amgen Inc. (AMGN) EPS growth is (39.4%), compared to the industry median of (14.0%) and the 5-year historical average of (6.7%).
The Amgen Inc. (AMGN) Free Cash Flow growth is 41.2%, compared to the industry median of 18.6% and the 5-year historical average of (2.9%).